Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Mirati therapeutics, inc. symbols : LLY save search
Global Lumakras Drug Market By Therapy Type, Disease Indication, and Region (Including COVID-19 Impact Analysis): A Report by Absolute Markets Insights
Published: 2022-03-14 (Crawled : 16:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.01%
H: 0.71%
C: 0.0%
RVMD | $35.56 -1.93% -1.97% 1.2M
|
Health Technology
|
| O: 0.15%
H: 0.72%
C: -9.31%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 1.45%
H: 18.94%
C: 7.04%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.78%
H: 3.11%
C: -5.4%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
covid-19 lumakras drug covid disease report therapy
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG A | $130.52 0.07% 0.0% 1.6M
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
space spac
Mirati Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-08-05 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.46%
H: 5.72%
C: 4.57%
financial results results
First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research
Published: 2021-06-04 (Crawled : 20:00) - biospace.com/
MCK | $535.42 0.64% 0.0% 420K
|
Distribution Services
|
| O: 0.27%
H: 0.48%
C: 0.29%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.04%
H: 0.82%
C: -0.38%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 3.38%
H: 1.58%
C: -0.87%
ongoing test results research biomarkers
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.